Puma Biotechnology, Inc.
NASDAQ:PBYI · NASDAQ Global Select
+$0.16 today
Vol 0.33M · Avg 0.26M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+125.67%
Period High
$7.80
Period Low
$3.07
Latest
$7.56
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$486.52M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$343.72M
Abeona Therapeutics Inc.
NASDAQ:ABEO
$325.16M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$265.73M
Eledon Pharmaceuticals, Inc.
NASDAQ:ELDN
$226.63M
Voyager Therapeutics, Inc.
NASDAQ:VYGR
$223.26M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$216.99M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$211.47M
Humacyte, Inc.
NASDAQ:HUMA
$154.04M
What is the latest PBYI filing?
The latest filing shown is 8-K dated Jun 16, 2026.
How many recent filings does PBYI have?
Intrinsic Alpha currently shows 20 recent filings for PBYI.
Explore More
Continue the stock analysis
Jump to another research area for this company.